Company / Operating Cash Flow per Share
Arcturus Therapeutics Holdings Inc. Operating Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$2.75
FY2025
5-year range
-$5.16 / -$0.68
FY2021-FY2025
Trend
-23.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share has fluctuated over the past 7 years, ranging from $-5.16 in FY2021 to $-0.68 in FY2023.
Based on SEC 10-K filings.
-2.75 in FY2025.
Declined from $-0.68 to $-2.75 over the past 2 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 23.5% year-over-year.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.06 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.75 | -23.5% |
| FY2024 | -$2.23 | -226.8% |
| FY2023 | -$0.68 | +86.7% |
| FY2022 | -$5.12 | +0.7% |
| FY2021 | -$5.16 | -276.0% |
| FY2020 | -$1.37 | +29.2% |
| FY2019 | -$1.94 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026